{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:15:39Z","timestamp":1777932939121,"version":"3.51.4"},"reference-count":40,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Rejuvenation Research"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:p>\n                    Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase, being involved in endothelial dysfunction. Furthermore, ADMA levels have been shown to predict future cardiovascular events in patients with coronary risk factors, such as diabetes and hypertension. We have previously found that glyceraldehyde-derived advanced glycation end products (glycer-AGEs) stimulate ADMA generation\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    and the levels are associated with ADMA, endothelial dysfunction, and vascular inflammation in humans. However, it remains unclear what structurally distinct glycer-AGEs are independent correlates of ADMA. In this study, we addressed the issue. We measured serum levels of protein-bound and free methylglyoxal-derived hydroimidazolone-1 (MG-H1) and argpyrimidine, two major structurally identified glycer-AGEs by liquid chromatography-tandem mass spectrometry in 128 outpatients, and examined the correlations of these AGEs, vascular stiffness, and inflammation with ADMA. Moreover, we examined whether the changes in serum MG-H1 and argpyrimidine levels after 4-month treatment with oral hypoglycemic agents (OHAs) were associated with those of ADMA in other 44 patients with impaired glucose tolerance or type 2 diabetes. Multiple stepwise regression analysis revealed that protein-bound MG-H1, high-density lipoprotein cholesterol (inversely), high-sensitivity C-reactive protein, and cardio-ankle vascular index were independently correlated with ADMA (\n                    <jats:italic toggle=\"yes\">R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.259). Treatment with OHAs significantly decreased ADMA levels in 44 glucose-intolerant or type 2 diabetic patients, and the changes in protein-bound MG-H1 levels were positively associated with those in ADMA values (\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    \u2009&lt;\u20090.05). This study demonstrates that serum levels of protein-bound MG-H1 are independently correlated with ADMA and may be a therapeutic target for cardiovascular disease.\n                  <\/jats:p>","DOI":"10.1089\/rej.2018.2152","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T04:25:36Z","timestamp":1547871936000},"page":"431-438","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum Levels of Protein-Bound Methylglyoxal-Derived Hydroimidazolone-1 are Independently Correlated with Asymmetric Dimethylarginine"],"prefix":"10.1177","volume":"22","author":[{"given":"Nobuhiro","family":"Tahara","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchia","family":"Kojima","sequence":"additional","affiliation":[{"name":"Division of Bioscience and Bioenvironmental Sciences, Faculty of Agriculture, Graduate School of Kyushu University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Division of Bioscience and Bioenvironmental Sciences, Faculty of Agriculture, Graduate School of Kyushu University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munehisa","family":"Bekki","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Tahara","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Maeda","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Honda","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiyo","family":"Igata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Sun","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Matsui","sequence":"additional","affiliation":[{"name":"Division of Bioscience and Bioenvironmental Sciences, Faculty of Agriculture, Graduate School of Kyushu University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho-Ichi","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,10,17]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2011.05.009"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.12.017"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.306301"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.398"},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.2174\/13816128113199990480","article-title":"Role of asymmetric dimethylarginine in cardiorenal syndrome","volume":"20","author":"Ueda S","year":"2014","unstructured":"Ueda S, , Yamagishi S, , Yokoro M, , Okuda S. Role of asymmetric dimethylarginine in cardiorenal syndrome. Curr Pharm Des, 2014; 20:2448\u20132455.","journal-title":"Curr Pharm Des"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.3.765"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.9.1141"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.18.1842"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001632"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005010076"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000181286.44222.61"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)07217-8"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep44692"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1089\/rej.2012.1335"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2013.06.009"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-013-0453-1"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2015.00067"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0215"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2016.1111873"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/1479164113486662"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.07.299"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.09.016"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1435"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0087"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/db14-1516","article-title":"Hidden complexities in the measurement of fructosyl-lysine and advanced glycation end products for risk prediction of vascular complications of diabetes","volume":"64","author":"Rabbani N","year":"2015","unstructured":"Rabbani N, , Thornalley PJ. Hidden complexities in the measurement of fructosyl-lysine and advanced glycation end products for risk prediction of vascular complications of diabetes. Diabetes, 2015; 64:9\u201311.","journal-title":"Diabetes"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/1479164117715855"},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1271\/bbb.70455","article-title":"The formation of argpyrimidine in glyceraldehyde-related glycation","volume":"72","author":"Usui T","year":"2008","unstructured":"Usui T, , Ohguchi M, , Watanabe H, , Hayase F. The formation of argpyrimidine in glyceraldehyde-related glycation. Biosci Biotechnol Biochem, 2008; 72:568\u2013571.","journal-title":"Biosci Biotechnol Biochem"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3896"},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1021\/ac400294q","article-title":"Highly-sensitive detection of free advanced glycation end-products by liquid chromatography-electrospray ionization-tandem mass spectrometry with 2,4,6-trinitrobenzene sulfonate derivatization","volume":"85","author":"Hashimoto C","year":"2013","unstructured":"Hashimoto C, , Iwaihara Y, , Chen SJ, , Tanaka M, , Watanabe T, , Matsui T. Highly-sensitive detection of free advanced glycation end-products by liquid chromatography-electrospray ionization-tandem mass spectrometry with 2,4,6-trinitrobenzene sulfonate derivatization. Anal Chem, 2013; 85:4289\u20134295.","journal-title":"Anal Chem"},{"key":"e_1_3_3_31_2","first-page":"pii","article-title":"Methylglyoxal-derived hydroimidazolone residue of plasma protein can behave as a predictor of prediabetes in Spontaneously Diabetic Torii rats","volume":"3","author":"Chen SJ","year":"2015","unstructured":"Chen SJ, , Aikawa C, , Yoshida R, , Matsui T. Methylglyoxal-derived hydroimidazolone residue of plasma protein can behave as a predictor of prediabetes in Spontaneously Diabetic Torii rats. Physiol Rep, 2015; 3: pii: e12477.","journal-title":"Physiol Rep"},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/ATVBAHA.116.307293","article-title":"Vascular Inflammation Evaluated by [18F]-Fluorodeoxyglucose-Positron Emission Tomography\/Computed Tomography Is Associated With Endothelial Dysfunction","volume":"36","author":"Honda A","year":"2016","unstructured":"Honda A, , Tahara N, , Nitta Y, et al. Vascular Inflammation Evaluated by [18F]-Fluorodeoxyglucose-Positron Emission Tomography\/Computed Tomography Is Associated With Endothelial Dysfunction. Arterioscler Thromb Vasc Biol, 2016; 36:1980\u20131988.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_3_3_33_2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2174\/1570161114666160625090212","article-title":"Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients","volume":"14","author":"Tahara N","year":"2016","unstructured":"Tahara N, , Yamagishi SI, , Bekki M, et al. Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients. Curr Vasc Pharmacol, 2016; 14:552\u2013562.","journal-title":"Curr Vasc Pharmacol"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2011.08.007"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090614"},{"key":"e_1_3_3_36_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2337\/dc16-1875","article-title":"Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study","volume":"40","author":"Saremi A","year":"2017","unstructured":"Saremi A, , Howell S, , Schwenke DC, et al. Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study. Diabetes Care, 2017; 40:591\u2013598.","journal-title":"Diabetes Care"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.2337\/db16-0310"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht402"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000231640.32543.11"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.10.2465"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ki.1989.14","article-title":"Urine glyceraldehyde excretion is elevated in the renal Fanconi syndrome","volume":"35","author":"Jonas AJ","year":"1989","unstructured":"Jonas AJ, , Lin SN, , Conley SB, , Schneider JA, , Williams JC, , Caprioli RC. Urine glyceraldehyde excretion is elevated in the renal Fanconi syndrome. Kidney Int, 1989; 35:99\u2013104.","journal-title":"Kidney Int"}],"container-title":["Rejuvenation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/rej.2018.2152","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/rej.2018.2152","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/rej.2018.2152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:34:43Z","timestamp":1777685683000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/rej.2018.2152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1089\/rej.2018.2152"],"URL":"https:\/\/doi.org\/10.1089\/rej.2018.2152","relation":{},"ISSN":["1549-1684","1557-8577"],"issn-type":[{"value":"1549-1684","type":"print"},{"value":"1557-8577","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}